Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.885 USD | -2.53% | +18.03% | -29.58% |
13/05 | Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating | MT |
10/05 | Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.58% | 392M | |
+28.40% | 48.16B | |
-0.35% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.62% | 25.59B | |
-22.83% | 18.96B | |
+8.55% | 12.92B | |
+29.80% | 12.03B | |
-2.31% | 11.77B |
- Stock Market
- Equities
- ORGO Stock
- News Organogenesis Holdings Inc.
- Transcript : Organogenesis Holdings Inc. Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-11-2023 08